-+ 0.00%
-+ 0.00%
-+ 0.00%

ROYALTY PHARMA: FULL YEAR 2026 GUIDANCE: PORTFOLIO RECEIPTS EXPECTED TO BE $3,275 MILLION TO $3,425 MILLION

Reuters·02/11/2026 12:00:04

Please log in to view news